These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 20156536

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM, MacRitchie HB, Marriott C, Martin GP.
    Int J Pharm; 2007 Mar 21; 333(1-2):45-55. PubMed ID: 17064863
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Agglomerate properties and dispersibility changes of salmeterol xinafoate from powders for inhalation after storage at high relative humidity.
    Das S, Larson I, Young P, Stewart P.
    Eur J Pharm Sci; 2009 Jun 28; 37(3-4):442-50. PubMed ID: 19491036
    [Abstract] [Full Text] [Related]

  • 8. Electrostatic characterisation of inhaled powders: effect of contact surface and relative humidity.
    Elajnaf A, Carter P, Rowley G.
    Eur J Pharm Sci; 2006 Dec 28; 29(5):375-84. PubMed ID: 16952450
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C, MacRitchie HB, Zeng XM, Martin GP.
    Int J Pharm; 2006 Dec 01; 326(1-2):39-49. PubMed ID: 16942848
    [Abstract] [Full Text] [Related]

  • 12. Influence of fine lactose and magnesium stearate on low dose dry powder inhaler formulations.
    Guchardi R, Frei M, John E, Kaerger JS.
    Int J Pharm; 2008 Feb 04; 348(1-2):10-7. PubMed ID: 17689898
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Moisture sorption, compressibility and caking of lactose polymorphs.
    Listiohadi Y, Hourigan JA, Sleigh RW, Steele RJ.
    Int J Pharm; 2008 Jul 09; 359(1-2):123-34. PubMed ID: 18485633
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Functionality testing of inhalation grade lactose.
    Steckel H, Markefka P, TeWierik H, Kammelar R.
    Eur J Pharm Biopharm; 2004 May 09; 57(3):495-505. PubMed ID: 15093599
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers.
    Schiavone H, Palakodaty S, Clark A, York P, Tzannis ST.
    Int J Pharm; 2004 Aug 20; 281(1-2):55-66. PubMed ID: 15288343
    [Abstract] [Full Text] [Related]

  • 19. The relationship between drug concentration, mixing time, blending order and ternary dry powder inhalation performance.
    Jones MD, Santo JG, Yakub B, Dennison M, Master H, Buckton G.
    Int J Pharm; 2010 May 31; 391(1-2):137-47. PubMed ID: 20211715
    [Abstract] [Full Text] [Related]

  • 20. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH, Hagedoorn P, Gjaltema D, Goede J, Frijlink HW.
    Int J Pharm; 2006 Mar 09; 310(1-2):81-9. PubMed ID: 16442246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.